BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 27286290)

  • 1. Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1.
    Natarajan K; Xie Y; Nakanishi T; Moreci RS; Jeyasuria P; Hussain A; Ross DD
    J Vis Exp; 2016 May; (111):. PubMed ID: 27286290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcrp1 transcription in mouse testis is controlled by a promoter upstream of a novel first exon (E1U) regulated by steroidogenic factor-1.
    Xie Y; Natarajan K; Bauer KS; Nakanishi T; Beck WT; Moreci RS; Jeyasuria P; Hussain A; Ross DD
    Biochim Biophys Acta; 2013 Dec; 1829(12):1288-99. PubMed ID: 24189494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of the major alternative promoter regulating Bcrp1/Abcg2 expression in the mouse intestine.
    Natarajan K; Xie Y; Nakanishi T; Beck WT; Bauer KS; Ross DD
    Biochim Biophys Acta; 2011 Jul; 1809(7):295-305. PubMed ID: 21718815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mouse Abcg2 mRNA during hematopoiesis is regulated by alternative use of multiple leader exons and promoters.
    Zong Y; Zhou S; Fatima S; Sorrentino BP
    J Biol Chem; 2006 Oct; 281(40):29625-32. PubMed ID: 16885162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 5' untranslated region variants of BCRP mRNA are differentially expressed in drug-selected cancer cells and in normal human tissues: implications for drug resistance, tissue-specific expression, and alternative promoter usage.
    Nakanishi T; Bailey-Dell KJ; Hassel BA; Shiozawa K; Sullivan DM; Turner J; Ross DD
    Cancer Res; 2006 May; 66(10):5007-11. PubMed ID: 16707421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Functional Transcriptional Binding Sites within Chicken
    Zhang Y; Huang J; Li X; Fang C; Wang L
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32050731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene.
    Bailey-Dell KJ; Hassel B; Doyle LA; Ross DD
    Biochim Biophys Acta; 2001 Sep; 1520(3):234-41. PubMed ID: 11566359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer-resistance protein (BCRP1) in the fetal mouse brain: development and glucocorticoid regulation.
    Petropoulos S; Gibb W; Matthews SG
    Biol Reprod; 2011 Apr; 84(4):783-9. PubMed ID: 21159928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative promoter usage and differential expression of multiple transcripts of mouse Prkar1a gene.
    Banday AR; Azim S; Tabish M
    Mol Cell Biochem; 2011 Nov; 357(1-2):263-74. PubMed ID: 21638026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multiple untranslated first exons and promoters system of the oestrogen receptor gene in the brain and peripheral tissues of the rat and monkey and the developing rat cerebral cortex.
    Kato J; Hirata S; Koh T; Yamada-Mouri N; Hoshi K; Okinaga S
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):281-93. PubMed ID: 9699882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-302a/b/c/d cooperatively inhibit BCRP expression to increase drug sensitivity in breast cancer cells.
    Wang Y; Zhao L; Xiao Q; Jiang L; He M; Bai X; Ma M; Jiao X; Wei M
    Gynecol Oncol; 2016 Jun; 141(3):592-601. PubMed ID: 26644266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
    Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein.
    Kennedy MA; Venkateswaran A; Tarr PT; Xenarios I; Kudoh J; Shimizu N; Edwards PA
    J Biol Chem; 2001 Oct; 276(42):39438-47. PubMed ID: 11500512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
    Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
    Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice.
    Marchetti S; de Vries NA; Buckle T; Bolijn MJ; van Eijndhoven MA; Beijnen JH; Mazzanti R; van Tellingen O; Schellens JH
    Mol Cancer Ther; 2008 Aug; 7(8):2280-7. PubMed ID: 18723475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
    González-Lobato L; Real R; Prieto JG; Alvarez AI; Merino G
    Eur J Pharmacol; 2010 Oct; 644(1-3):41-8. PubMed ID: 20655304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of STAT5 and epigenetics in lactation-associated upregulation of multidrug transporter ABCG2 in the mammary gland.
    Wu AM; Yang M; Dalvi P; Turinsky AL; Wang W; Butcher D; Egan SE; Weksberg R; Harper PA; Ito S
    Am J Physiol Endocrinol Metab; 2014 Oct; 307(7):E596-610. PubMed ID: 25117410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.
    Merino G; van Herwaarden AE; Wagenaar E; Jonker JW; Schinkel AH
    Mol Pharmacol; 2005 May; 67(5):1765-71. PubMed ID: 15722455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal expression of mouse Abcg2/breast cancer resistance protein (BCRP) gene is under control of circadian clock-activating transcription factor-4 pathway.
    Hamdan AM; Koyanagi S; Wada E; Kusunose N; Murakami Y; Matsunaga N; Ohdo S
    J Biol Chem; 2012 May; 287(21):17224-17231. PubMed ID: 22396548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of the ABCG2 5' non-coding exon variants: Stem cell specificity, translation efficiency and the influence of drug selection.
    Sándor S; Jordanidisz T; Schamberger A; Várady G; Erdei Z; Apáti Á; Sarkadi B; Orbán TI
    Biochim Biophys Acta; 2016 Jul; 1859(7):943-51. PubMed ID: 27191194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.